AbleChild Board Member Responds to New York Times ArticlePrint This Post
Letter to Editor 11/17/14
New York Times
The article “One Drug or 2? Parents See Risk but Also Hope” by Alan Schwarz (New York Times, 11/15/14, A-1) should be titled: “One Drug or 15?” — much more like what goes on in US psychiatry and schools.
The time has come to stop the “mental illness”/ “psychiatric disease” fraud whereby millions upon millions of entirely normal children and adults the world-over are poisoned in the name of psychiatric drug “treatment.”
On November 10, 2008, Director General of Health Canada, Supriya Sharma (letter to Canadian father, B. Verbeek), wrote:
“For mental/psychiatric disorders in general, including depression, anxiety, schizophrenia and ADHD, there are no confirmatory gross, microscopic or chemical abnormalities that have been validated for objective physical diagnosis.”
This was followed, March 12, 2009, by a confession from Donald Dobbs of the US Food and Drug Administration (letter to F.A. Baughman Jr., MD) who wrote:
“I consulted with the FDA New Drug Review Division and they concurred with the response you enclosed from Health Canada.”
Having confessed there is no such thing as a physical abnormality/disease in all of psychiatry, both Health Canada and the US, Food & Drug Administration routinely (1) allow psychiatric “diagnoses” to be called physical abnormalities/diseases, (2) allow psychotropic drugs/compounds to be called “safe and effective,” when (3) each drug/compound is nothing but a poison making every normal individual/phenotype—abnormal. In time, irreversibly so.
Fred A. Baughman Jr., MD
Alan Schwarz, Dr. Baughman, FDA New Drug Review Division, New York Times, One Drug or 2, Psychiatry, psychiatry drugs